Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-27

Clinical Trial Update: Cross-linking for Corneal Ulcers Treatment Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cross-linking therapy for corneal ulcers completed, with results posted on 2024-08-27. The sponsor was University of California, San …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Corneal Ulcer, Infectious Keratitis | Phase 3 | Status: COMPLETED | Results posted: 2024-08-27